M. Michael Wolfe

9.1k total citations · 1 hit paper
138 papers, 7.0k citations indexed

About

M. Michael Wolfe is a scholar working on Surgery, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, M. Michael Wolfe has authored 138 papers receiving a total of 7.0k indexed citations (citations by other indexed papers that have themselves been cited), including 71 papers in Surgery, 39 papers in Cellular and Molecular Neuroscience and 36 papers in Molecular Biology. Recurrent topics in M. Michael Wolfe's work include Helicobacter pylori-related gastroenterology studies (48 papers), Neuropeptides and Animal Physiology (38 papers) and Neuroendocrine Tumor Research Advances (31 papers). M. Michael Wolfe is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (48 papers), Neuropeptides and Animal Physiology (38 papers) and Neuroendocrine Tumor Research Advances (31 papers). M. Michael Wolfe collaborates with scholars based in United States, Japan and Germany. M. Michael Wolfe's co-authors include David R. Lichtenstein, Gurkirpal Singh, James E. McGuigan, Michael O. Boylan, Rupert G. Yip, George Sachs, Timothy J. Kieffer, Linda A. Jarboe, Robert T. Jensen and Min Yao and has published in prestigious journals such as Science, New England Journal of Medicine and Proceedings of the National Academy of Sciences.

In The Last Decade

M. Michael Wolfe

132 papers receiving 6.6k citations

Hit Papers

Gastrointestinal Toxicity of Nonsteroidal Antiinflammator... 1999 2026 2008 2017 1999 400 800 1.2k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M. Michael Wolfe United States 42 3.0k 1.8k 1.5k 1.4k 1.2k 138 7.0k
Lucio C. Rovati Italy 45 1.8k 0.6× 2.0k 1.1× 1.2k 0.8× 806 0.6× 508 0.4× 213 7.2k
Franco Cuccurullo Italy 52 1.8k 0.6× 940 0.5× 1.5k 1.0× 741 0.5× 391 0.3× 193 9.1k
Antonio Morelli Italy 46 2.5k 0.8× 752 0.4× 1.1k 0.7× 217 0.2× 1.6k 1.3× 112 7.3k
Giovanni Ghirlanda Italy 49 2.7k 0.9× 492 0.3× 1.5k 1.0× 2.4k 1.7× 301 0.2× 207 8.0k
Goro Kajiyama Japan 53 4.1k 1.4× 239 0.1× 2.0k 1.3× 745 0.5× 1.1k 0.9× 434 10.0k
A. Dembińska-Kieć Poland 36 1.1k 0.4× 955 0.5× 1.7k 1.1× 634 0.4× 144 0.1× 218 5.8k
Atsunori Kashiwagi Japan 55 2.2k 0.8× 592 0.3× 4.2k 2.7× 3.5k 2.5× 166 0.1× 231 11.3k
Bernhard A. Peskar Germany 42 1.1k 0.4× 2.4k 1.3× 1.3k 0.8× 325 0.2× 207 0.2× 190 6.3k
Enar Carlsson Sweden 29 1.7k 0.6× 196 0.1× 1.4k 0.9× 327 0.2× 954 0.8× 81 4.2k
Barry J. Gertz United States 37 1.0k 0.4× 1.9k 1.1× 1.4k 0.9× 449 0.3× 80 0.1× 69 5.9k

Countries citing papers authored by M. Michael Wolfe

Since Specialization
Citations

This map shows the geographic impact of M. Michael Wolfe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Michael Wolfe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Michael Wolfe more than expected).

Fields of papers citing papers by M. Michael Wolfe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Michael Wolfe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Michael Wolfe. The network helps show where M. Michael Wolfe may publish in the future.

Co-authorship network of co-authors of M. Michael Wolfe

This figure shows the co-authorship network connecting the top 25 collaborators of M. Michael Wolfe. A scholar is included among the top collaborators of M. Michael Wolfe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Michael Wolfe. M. Michael Wolfe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wolfe, M. Michael, Michael O. Boylan, & W W Chin. (2025). Glucose-Dependent Insulinotropic Polypeptide in Incretin Physiology: Role in Health and Disease. Endocrine Reviews. 46(4). 479–500. 7 indexed citations
3.
Jarman, Angela F., M. Michael Wolfe, Bryn E. Mumma, et al.. (2024). The Role of Sex and Gender in Precision Emergency Medicine: A Scoping Review and Proposed Hierarchy. Clinical Therapeutics. 46(12). 974–981. 1 indexed citations
4.
Boylan, Michael O., et al.. (2019). Effects of gastric inhibitory polypeptide (GIP) immunoneutralization on mouse motor coordination and memory. Peptides. 125. 170227–170227. 1 indexed citations
5.
Jepeal, Lisa I., Michael O. Boylan, & M. Michael Wolfe. (2008). GATA-4 upregulates glucose-dependent insulinotropic polypeptide expression in cells of pancreatic and intestinal lineage. Molecular and Cellular Endocrinology. 287(1-2). 20–29. 20 indexed citations
6.
Spina, Catherine S., Vin Tangpricha, Min Yao, et al.. (2005). Colon cancer and solar ultraviolet B radiation and prevention and treatment of colon cancer in mice with vitamin D and its Gemini analogs. The Journal of Steroid Biochemistry and Molecular Biology. 97(1-2). 111–120. 39 indexed citations
7.
Yao, Min, et al.. (2004). Cyclooxygenase-2 selective inhibition with NS-398 suppresses proliferation and invasiveness and delays liver metastasis in colorectal cancer. British Journal of Cancer. 90(3). 712–719. 96 indexed citations
8.
Moore, Tereza, Lisa I. Jepeal, Michael O. Boylan, et al.. (2004). Gastrin stimulates receptor-mediated proliferation of human esophageal adenocarcinoma cells. Regulatory Peptides. 120(1-3). 195–203. 21 indexed citations
9.
Corley, Douglas A., Philip O. Katz, John M. Wo, et al.. (2003). Improvement of gastroesophageal reflux symptoms after radiofrequency energy: a randomized, sham-controlled trial. Gastroenterology. 125(3). 668–676. 210 indexed citations
10.
Wolfe, M. Michael. (2003). Managing gastroesophageal reflux disease: from pharmacology to the clinical arena. Gastroenterology Clinics of North America. 32(3). S37–S46. 4 indexed citations
12.
Wolfe, M. Michael, et al.. (2001). Clinical Potential of Cyclo-Oxygenase-2 Inhibitors. BioDrugs. 15(9). 563–572. 13 indexed citations
13.
Jarboe, Linda A., et al.. (2001). Patterns of proton pump inhibitor use in clinical practice. The American Journal of Medicine. 111(6). 469–473. 57 indexed citations
14.
Wolfe, M. Michael. (2000). An overview of gastroesophageal reflux disease. The American Journal of Managed Care. 6. 1 indexed citations
15.
Wolfe, M. Michael & George Sachs. (2000). Acid suppression: Optimizing therapy for gastroduodenal ulcer healing, gastroesophageal reflux disease, and stress-related erosive syndrome. Gastroenterology. 118(2). S9–S31. 252 indexed citations
16.
Yip, Rupert G. & M. Michael Wolfe. (1999). GIF biology and fat metabolism. Life Sciences. 66(2). 91–103. 237 indexed citations
17.
Wolfe, M. Michael. (1996). NSAIDs and the Gastrointestinal Mucosa. Hospital Practice. 31(12). 37–48. 11 indexed citations
18.
Freston, James W., Kurt Borch, Stephen J. Brand, et al.. (1995). Effects of hypochlorhydria and hypergastrinemia on structure and function of gastrointestinal cells. Digestive Diseases and Sciences. 40(S2). 50S–62S. 45 indexed citations
19.
Lichtenberger, Lenard M., Elizabeth J. Dial, Jimmy J. Romero, et al.. (1995). Role of luminal ammonia in the development of gastropathy and hypergastrinemia in the rat. Gastroenterology. 108(2). 320–329. 39 indexed citations
20.
Karnik, Pratima, Holly Dushkin, & M. Michael Wolfe. (1992). Somatostatin inhibition of gastrin gene expression: involvement of pertussis toxin-sensitive and -insensitive pathways. Regulatory Peptides. 38(3). 167–177. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026